Evaluate the effect of intravitreal Bevacizumab injection for ocular proliferative diseases
Not Applicable
- Conditions
- choroidal neovascularization,proliferative diabetic retinopathy, central retinal vein occlusion neovascular glaucoma
- Registration Number
- JPRN-UMIN000020467
- Lead Sponsor
- agasaki University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Patients physician has judged inappropriate and comprehensive evaluation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual acuity
- Secondary Outcome Measures
Name Time Method Intra ocular pressure The degree of ischemia with fluorescein angiography Central retinal thickness